CUE (Cue Biopharma Inc.) Rasio nilai perusahaan marang dodolan

Logo perusahaan publik Cue Biopharma, Inc. (CUE)

Cue Biopharma, Inc. (CUE) is deploying reserves toward costly R&D focused on T-cell control. The development of Immuno-STAT targets the global immuno-oncology market by mimicking natural signals. The company's current price-to-sales valuation confirms the asset's dynamics, where -313.97 is recorded as the baseline value. However, uncertainty regarding partner payments and a capital deficit prior to commercialization create significant risks for investors.

CUE (Cue Biopharma Inc.) riwayat Multiplikator EV/Sales saka 23.11.2025 nganti 20.11.2026

CUE (Cue Biopharma, Inc.): rincian analitis lan laporan miturut indikator

- rega lan prakiraan konsensus rega:
Pambiji fundamental perusahaan:CUE - cuebiopharma.com
Barang utama Cue Biopharma Inc.

To minimize the risk of overpaying for an asset, it is necessary to analyze the Enterprise Value to Revenue (EV/Revenue) ratio, which strips the valuation of the impact of debt load. On the GURU.Markets platform, the EV/Sales multiple allows for a comparison of Cue Biopharma, Inc. (CUE) market capitalization against its actual revenues, which is critically important for a non-cyclical, pre-revenue biopharmaceutical business that is completely isolated from macroeconomic shocks and inflation.

Analisis pesaing

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|compasstherapeutics.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Replimune Inc.|Lyell Immunopharma (LYEL) - Rasio nilai perusahaan marang pendapatan|Innate Pharma S.A. - Nilai bisnis marang pendapatan|PYXS (Pyxis) - Multiplikator EV/Sales|Multiplikator EV/Sales cgen.com|Rasio nilai perusahaan marang pendapatan IO Biotech (IOBT)|STRO: Nilai perusahaan marang volume dodolan|MiNK Therapeutics Inc. - Nilai perusahaan marang pendapatan|werewolftx.com (HOWL) - Multiplikator nilai perusahaan marang pendapatan|Immix Biopharma Inc. - Multiplikator EV/Sales|ALXO - Multiplikator EV/Sales|PDSB: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings Inc. (SONN)|MAIA (MAIABiotech.com) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Liminatus Pharma (LIMN)|Multiplikator EV/Sales LVTX|Koefisien nilai perusahaan marang pendapatan NXTC|Leap Therapeutics, Inc. - Nilai perusahaan marang pendapatan|INTS: Rasio nilai perusahaan marang pendapatan|Sensei Biotherapeutics Inc - Multiplikator EV/Sales|TOVX: Rasio nilai perusahaan marang pendapatan|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP